Published in Gene Therapy Weekly, December 9th, 2010
"Clearance of A beta from the brain represents an important therapeutic strategy for prevention and treatment of AD. Immunotherapy targeting A beta is effective to remove the peptide from the brain. However, it is associated with detrimental adverse effects, such...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.